BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11823118)

  • 1. Improved renal clearance and tumor targeting of 99mTc-labeled anti-Tac monoclonal antibody Fab by chemical modifications.
    Kim MK; Jeong HJ; Kao CH; Yao Z; Paik DS; Pie JE; Kobayashi H; Waldmann TA; Carrasquillo JA; Paik CH
    Nucl Med Biol; 2002 Feb; 29(2):139-46. PubMed ID: 11823118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetic characteristics of glycolated humanized anti-Tac Fabs are determined by their isoelectric points.
    Kobayashi H; Le N; Kim IS; Kim MK; Pie JE; Drumm D; Paik DS; Waldmann TA; Paik CH; Carrasquillo JA
    Cancer Res; 1999 Jan; 59(2):422-30. PubMed ID: 9927057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical modification to reduce renal uptake of disulfide-bonded variable region fragment of anti-Tac monoclonal antibody labeled with 99mTc.
    Kim IS; Yoo TM; Kobayashi H; Kim MK; Le N; Wang QC; Pastan I; Carrasquillo JA; Paik CH
    Bioconjug Chem; 1999; 10(3):447-53. PubMed ID: 10346877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Favorable effects of glycolate conjugation on the biodistribution of humanized antiTac Fab fragment.
    Kobayashi H; Kim IS; Drumm D; Kim MK; Paik DS; Le N; Waldmann TA; Carrasquillo JA; Paik CH
    J Nucl Med; 1999 May; 40(5):837-45. PubMed ID: 10319759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lowering of pI by acylation improves the renal uptake of 99mTc-labeled anti-Tac dsFv: effect of different acylating reagents.
    Kim I; Kobayashi H; Yoo TM; Kim MK; Le N; Han ES; Wang QC; Pastan I; Carrasquillo JA; Paik CH
    Nucl Med Biol; 2002 Nov; 29(8):795-801. PubMed ID: 12453588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor.
    Burvenich IJ; Schoonooghe S; Blanckaert P; Bacher K; Vervoort L; Coene E; Mertens N; De Vos F; Slegers G
    Nucl Med Biol; 2007 Apr; 34(3):257-65. PubMed ID: 17383575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Evaluation of
    Shi D; Fu W; Tan H; Lin Q; Shi H; Cheng D
    Mol Pharm; 2024 Jan; 21(1):303-312. PubMed ID: 38109713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations.
    Steffens MG; Oosterwijk E; Kranenborg MH; Manders JM; Debruyne FM; Corstens FH; Boerman OC
    J Nucl Med; 1999 May; 40(5):829-36. PubMed ID: 10319758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.
    Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW
    Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor pretargeting in mice using (99m)Tc-labeled morpholino, a DNA analog.
    Liu G; Mang'era K; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
    J Nucl Med; 2002 Mar; 43(3):384-91. PubMed ID: 11884499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reagents for astatination of biomolecules. 5. Evaluation of hydrazone linkers in (211)At- and (125)I-labeled closo-decaborate(2-) conjugates of Fab' as a means of decreasing kidney retention.
    Wilbur DS; Chyan MK; Hamlin DK; Nguyen H; Vessella RL
    Bioconjug Chem; 2011 Jun; 22(6):1089-102. PubMed ID: 21513347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m labeling and biodistribution of anti-TAC disulfide-stabilized Fv fragment.
    Yoo TM; Chang HK; Choi CW; Webber KO; Le N; Kim IS; Eckelman WC; Pastan I; Carrasquillo JA; Paik CH
    J Nucl Med; 1997 Feb; 38(2):294-300. PubMed ID: 9025758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of extrarenal plasma clearance and hepatic uptake of technetium-99m-mercaptoacetyltriglycine in cats.
    Drost WT; McLoughlin MA; Mattoon JS; Lerche P; Samii VF; DiBartola SP; Chew DJ; Barthez PY
    Am J Vet Res; 2003 Sep; 64(9):1076-80. PubMed ID: 13677382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and evaluation of the tumor imaging properties of 123I-labeled recombinant and enzymatically generated Fab fragments of the TAG-72 monoclonal antibody CC49.
    Tang Y; Yang S; Gariépy J; Scollard DA; Reilly RM
    Bioconjug Chem; 2007; 18(3):677-84. PubMed ID: 17361988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope blocking: positive and negative effects on the biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment of two antibodies against different epitopes of the circulating antigen.
    Kobayashi H; Sun BF; Han ES; Kim MK; Le N; Wang QC; Nelson DL; Pastan I; Waldmann TA; Paik CH; Carrasquillo JA
    Jpn J Cancer Res; 1998 Apr; 89(4):436-44. PubMed ID: 9617350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal and extrarenal clearance of 99mTc-MAG3: a comparison with 125I-OIH and 51Cr-EDTA in patients representing all levels of glomerular filtration rate.
    Rehling M; Nielsen BV; Pedersen EB; Nielsen LE; Hansen HE; Bacher T
    Eur J Nucl Med; 1995 Dec; 22(12):1379-84. PubMed ID: 8586082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-lysine effectively blocks renal uptake of 125I- or 99mTc-labeled anti-Tac disulfide-stabilized Fv fragment.
    Kobayashi H; Yoo TM; Kim IS; Kim MK; Le N; Webber KO; Pastan I; Paik CH; Eckelman WC; Carrasquillo JA
    Cancer Res; 1996 Aug; 56(16):3788-95. PubMed ID: 8706025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 99mTc-mercaptoacetyltriglycine and [131I]-o-iodohippurate elimination in perfused rat kidney.
    Trejtnar F; Laznicek M; Laznickova A
    Nucl Med Biol; 2003 Jan; 30(1):45-9. PubMed ID: 12493542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of 99mTc(Sn)- and 131I-labeled anti-carcinoembryonic antigen monoclonal antibody fragments in nude mice.
    Zimmer AM; Kazikiewicz JM; Rosen ST; Spies SM
    Cancer Res; 1987 Mar; 47(6):1691-4. PubMed ID: 3815365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.